Search Results 61-70 of 23923 for pharmacogenetics
About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of patients in ...
... pharmacogenetic guidelines for psychiatry. MEDIA CONTACT: Bob Nellis, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu. These comments are ...
Pharmacogenetic testing (such as cytochrome P450 2D6 and 2C19, serotonin transporter gene); Transcranial magnetic stimulation; Psychotherapy techniques (such ...
A Mayo Clinic genetic researcher. Recognized for its outstanding contributions to research, the Department of Clinical Genomics has a long history of published ...
... pharmacogenetics into primary care practice. Her publication list shows her broad but focused interests, and this is well reflected in her list of ...
Prospective participant selection and ranking to maximize actionable pharmacogenetic variants and discovery in the eMERGE Network. Genome Med. 2015;7(1):67 ...
Member — American Medical Informatics Association, Clinical Pharmacogenetics Implementation Consortium, HL7 Clinical Genomics, International Society for ...
About this study. A group of Mayo Clinic Biobank participants were genotyped for genetic variants as part of a separate study and a subset were found to be ...
Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...
Consider pharmacogenetic testing. These tests check for specific genes ... Currently, pharmacogenetics tests are not a sure way to show if a medication ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.